Your Questions, Answered
We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
The fluorophore will fluoresce when it binds to glucose. The amount of fluorescence directly corresponds to the amount of glucose in the interstitial fluid. If ambient light (like sunlight) is high enough to interfere with measuring that fluorescence, the system will display a High Ambient Light Alert. No glucose will be displayed until the condition is resolved by reducing the ambient light condition.
The proximity of the Eversense® E3 Sensor with medicated patches has not been studied. Please contact your health care professional for advisement.
Eversense® E3 is not indicated for use in children.
Eversense® E3 is a continuous glucose monitoring system indicated for the management of diabetes in adults age 18 years and older.
The Eversense® E3 Smart Transmitter, is water resistant to an Ingress Protection Rating of IP67. This means you can submerge in water 1 meter (3.2 feet) deep for up to 30 minutes. You can take showers and swim without extra protection.
Exposing the smart transmitter to conditions beyond this will result in damage and void your warranty.
The unit of measure is displayed on the My Glucose screen. (You select the unit of measure when the app is first downloaded and you log in the for the first time.) In order to change the unit of measure, you will need to delete/remove the App from your mobile device and download it again.
You can find the Transmitter serial number by looking at the back side of the Transmitter. The serial number is the 5-digit number listed next to “SN”.
You can also find the Transmitter Serial number in the Eversense® App that is connect to your Transmitter.
- Tap Menu > About > My Transmitter > Device information to display the Serial Number
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
MKT-001692 Rev 1